|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Phase II Multicenter, Double-blinded Clinical Trial of SP160412 in the Temporary Relief of Mild to Moderate (i.e,First Degree) Sunburn
A phase II multicenter, double-blinded clinical trial of the safety and efficacy of
SP160412 in the temporary relief of mild to moderate, (i.e. first degree) sunburn
100 Clinical Results associated with Sephoris Pharmaceuticals LLC
0 Patents (Medical) associated with Sephoris Pharmaceuticals LLC
100 Deals associated with Sephoris Pharmaceuticals LLC
100 Translational Medicine associated with Sephoris Pharmaceuticals LLC